Alliance A051301 (Large B-Cell Lymphoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to see how a drug called ibrutinib works in your body and against your cancer.
Large B-Cell Lymphoma that has returned after it was getting better
Who Can Participate in the Study?
Adults with Large B-Cell Lymphoma that has relapsed or not responded to treatment.
What is Involved?
If you choose to join this study, you will:
- Be randomly assigned (like flipping a coin) to 1 of 2 treatment groups
-- One group will receive the drug ibrutinib
-- The other group will receive placebo (an inactive substance)